Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes

Affiliations

• ¹ Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, UK. mg14606@bristol.ac.uk.
• ² Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, UK.
• ³ Department of Computer Science, Merchant Venturers Building, University of Bristol, Woodland Road, Bristol, BS8 1UB, UK.
• ⁴ Academic Unit of Ophthalmology, Translational Health Sciences, Bristol Medical School, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, UK.
• ⁵ Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, CA, La Jolla, 92037, USA.
• ⁶ School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2UH, UK.
• ⁷ Centre for Glycoscience, School of Life Sciences, Keele University, Staffordshire, ST5 5BG, UK.
• ⁸ Ferrier Research Institute, Victoria University of Wellington, 69 Gracefield Rd, Lower Hutt, 5046, New Zealand.
• ⁹ Bristol Eye Hospital, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, BS1 2LX, UK.